KEY PRODUCTS
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
01 1Chunghwa Chemical Synthesis & Biotech
01 1TACROLIMUS
01 1Taiwan
01 1Active
01 1Complete
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-01
Pay. Date : 2016-03-09
DMF Number : 18985
Submission : 2005-11-28
Status : Active
Type : II
20
Chunghwa Chemical Synthesis And Biotech Co Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
One of their notable products is TACROLIMUS, with a corresponding US DMF Number 18985.
Remarkably, this DMF maintains an Active status since its submission on November 28, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 01, 2016, and payment made on March 09, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
